MOTT DAVID M
SEC CIK 1219871 · EDGAR
BoughtSold
Most active insiders at NVAX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Draghia-Akli Ruxandra | Section 16 | — | — |
| 2 | O'Hara Elaine | EVP, Chief Strategy Off | — | — |
| 3 | Shiver John W. | Dir | — | — |
| 4 | Newton Charles W. | Dir | — | — |
| 5 | Jacobs John C | Pres, CEO, Dir | — | — |
| 6 | King Rachel K. | Dir | — | — |
| 7 | Kelly James Patrick | EVP, CFO, Treas | — | — |
| 8 | Casey Mark J | EVP, CLO | — | — |
| 9 | Alton Gregg H | Dir | — | — |
| 10 | Rodgers Richard J | Dir | — | — |
| 11 | MOTT DAVID M | Dir | — | — |
Transactions 25
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-23 19:51 | 2026-06-20 | NVAX | NOVAVAX INC | MOTT DAVID M | Dir | M - OptEx | — | +18.9K | 79.8K | +31% | — |
| DM | 2026-06-18 16:07 | 2026-06-16 | ARDX | ARDELYX, INC. | MOTT DAVID M | Dir | A - Grant | $0.00 | +46.7K | 3.35M | +1% | $0 |
| 2026-02-23 | 2026-02-20 | ARDX | ARDELYX, INC. | MOTT DAVID M | Dir | P - Purchase | $5.84 | +333.3K | 3.30M | +11% | +$1.95M | |
| DM | 2025-06-23 | 2025-06-18 | ARDX | ARDELYX, INC. | MOTT DAVID M | Dir | A - Grant | $0.00 | +72.7K | 2.97M | +3% | $0 |
| 2025-06-18 | 2025-06-16 | ARDX | ARDELYX, INC. | MOTT DAVID M | Dir | P - Purchase | $3.63 | +200.0K | 2.90M | +7% | +$726.0K | |
| D | 2025-06-13 | 2025-06-12 | NVAX | NOVAVAX INC | MOTT DAVID M | Dir | M - OptEx | $0.00 | +10.4K | 60.9K | +21% | $0 |
| 2025-06-11 | 2025-06-09 | ARDX | ARDELYX, INC. | MOTT DAVID M | Dir | P - Purchase | $3.69 | +200.0K | 2.70M | +8% | +$738.0K | |
| 2025-05-19 | 2025-05-15 | ARDX | ARDELYX, INC. | MOTT DAVID M | Dir | P - Purchase | $3.29 | +100.0K | 2.50M | +4% | +$329.0K | |
| 2025-05-05 | 2025-05-02 | ARDX | ARDELYX, INC. | MOTT DAVID M | Dir | P - Purchase | $4.22 | +381.4K | 2.40M | +19% | +$1.61M | |
| 2025-02-26 | 2025-02-24 | ARDX | ARDELYX, INC. | MOTT DAVID M | Dir | P - Purchase | $5.00 | +77.7K | 2.02M | +4% | +$388.6K | |
| 2025-01-22 | 2025-01-21 | ARDX | ARDELYX, INC. | MOTT DAVID M | Dir | P - Purchase | $4.99 | +199.0K | 1.94M | +11% | +$993.0K | |
| D | 2024-12-27 | 2024-12-26 | ARDX | ARDELYX, INC. | MOTT DAVID M | Dir | M - OptEx | $0.55 | +100.0K | 1.74M | +6% | +$55.0K |
| 2024-12-23 | 2024-12-19 | ARDX | ARDELYX, INC. | MOTT DAVID M | Dir | P - Purchase | $4.67 | +213.3K | 1.64M | +15% | +$996.1K | |
| 2024-11-14 | 2024-11-13 | ARDX | ARDELYX, INC. | MOTT DAVID M | Dir | P - Purchase | $4.62 | +215.9K | 1.43M | +18% | +$997.3K | |
| D | 2024-06-17 | 2024-06-14 | ARDX | ARDELYX, INC. | MOTT DAVID M | Dir | A - Grant | $0.00 | +17.3K | 1.21M | +1% | $0 |
| D | 2024-06-14 | 2024-06-12 | NVAX | NOVAVAX INC | MOTT DAVID M | Dir | M - OptEx | $0.00 | +6,670 | 50.5K | +15% | $0 |
| D | 2023-06-16 | 2023-06-15 | ARDX | ARDELYX, INC. | MOTT DAVID M | Dir | A - Grant | $0.00 | +25.5K | 1.19M | +2% | $0 |
| D | 2023-06-13 | 2023-06-10 | NVAX | NOVAVAX INC | MOTT DAVID M | Dir | M - OptEx | — | +3,100 | 43.8K | +8% | — |
| 2022-11-17 | 2022-11-17 | ARDX | ARDELYX, INC. | MOTT DAVID M | Dir | P - Purchase | $1.76 | +567.0K | 1.17M | +95% | +$997.9K | |
| D | 2022-06-21 | 2022-06-15 | ARDX | ARDELYX, INC. | MOTT DAVID M | Dir | A - Grant | $0.00 | +182.5K | 599.8K | +44% | $0 |
| D | 2022-06-21 | 2022-06-17 | NVAX | NOVAVAX INC | MOTT DAVID M | Dir | M - OptEx | — | +700 | 40.7K | +2% | — |
| M | 2022-02-23 | 2022-02-18+ | ELVN | Enliven Therapeutics, Inc. | MOTT DAVID M | Dir | P - Purchase | $1.45 | +151.5K | 194.0K | +356% | +$219.7K |
| M | 2022-02-17 | 2022-02-15+ | ELVN | Enliven Therapeutics, Inc. | MOTT DAVID M | Dir | P - Purchase | $1.19 | +45.9K | 63.2K | +267% | +$54.7K |
| M | 2022-02-14 | 2022-02-10+ | ELVN | Enliven Therapeutics, Inc. | MOTT DAVID M | Dir | P - Purchase | $1.23 | +31.8K | 31.8K | New | +$39.2K |
| M | 2021-09-24 | 2021-09-23 | NVAX | NOVAVAX INC | MOTT DAVID M | Dir | S - Sale | $252.90 | -25.0K | 59.2K | -30% | -$6.31M |
Purchase Sale Sale after option exercise All abbreviations